• Facebook
  • Twitter
  • Youtube
  • Instagram
  • LinkedIn
  • Rss
  • Store
  • Donate
NCCS - National Coalition for Cancer Survivorship
  • About
    • Our Mission
    • Our History
    • The 1986 Club
    • Our Team
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • State of Survivorship Survey
      • 2022 Survey
      • 2021 Survey
      • 2020 Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Advocate Engagement Opportunities
    • Survivorship Champions
    • Subscribe to NCCS Updates
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State-Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Cancer Rehabilitation
    • Integrative Oncology
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Telehealth
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • 2022 Winners
      • Awardees
      • Reception and Sponsorship
      • Committees
      • Nominations
    • Cancer Policy Roundtable (CPR)
      • Fall 2022 CPR
      • Spring 2022 CPR
      • Fall 2021 CPR
      • Spring 2021 CPR
      • Fall 2020 CPR
      • Spring 2020 CPR
    • Cancer Policy and Advocacy Team (CPAT) Virtual Symposium 2022
    • 2022 State of Survivorship Survey Results
    • Webinars
  • Contact Us
  • Search
  • Menu Menu
  • 0Shopping Cart

Your generous year-end donation will be matched $1 for $1    DONATE

NCCS Starburst 250px

What Caught Our Eye: Medicaid Coverage Limits; Cancer Care Cost Communication; Stanford Care Planning Study; Drug Pricing; and More

February 9, 2018/in Cancer News, Cancer Policy Blog Access to Care, Affordable Care Act, Care Planning, Drug Pricing, Financial Toxicity, Health Care Coverage, Health Equity, Quality Cancer Care NCCS News
What Caught Our Eye (WCOE), February 9, 2018
What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention.

Affordable Care Act

“After Approving Medicaid Work Requirements, Trump HHS Aims for Lifetime Coverage Limits”

.@HHSgov considering lifetime limits on #Medicaid coverage is very concerning. Would be devastating for #Cancer patients as many would be among first to hit limits due to high cost of cancer care, including those patients depending on Medicaid for their long-term follow-up care. https://t.co/DA6hBZ6pDs

— NCCS – National Coalition for Cancer Survivorship (@CancerAdvocacy) February 6, 2018

BREAKING: This would be the wrong direction for our country and millions of Americans.

https://t.co/jqeS9JNpUW

— Andy Slavitt @ 🏡 (@ASlavitt) February 6, 2018

By Tony Pugh, McClatchy News — After allowing states to impose work requirements for Medicaid enrollees, the trump administration is now pondering lifetime limits on adults’ access to coverage.

Capping health care benefits — like federal welfare benefits — would be a first for Medicaid, the joint state-and-federal health plan for low-income and disabled Americans.
Read More »

“Despite Changes That Undermined ACA Enrollment, Marketplaces ‘Remarkably Stable’”

Marketplace directors release report showing a mixed bag on ACA enrollment — and warn of sharp price hikes for 2019 if nothing is done. https://t.co/nYfplpxaZ9

— Julie Appleby (@Julie_appleby) February 8, 2018

By Julie Appleby, Kaiser Health News — After much drama leading to this year’s open enrollment for Affordable Care Act coverage — a shorter time frame, a sharply reduced federal budget for marketing and assistance, and confusion resulting from months of repeal-and-replace debate — the final tally paints a mixed picture.
Read More »

“Bipartisan Senate Budget Deal Boosts Health Programs”

next #WTHealth podcast coming tomorrow (waiting for outcome of budget fight). But meanwhile here's my and @shefalil's take on health items in the deal: https://t.co/jxqvIJ7f5G

— julie rovner (@jrovner) February 8, 2018

By Julie Rovner, NPR — In a rare show of bipartisanship for the mostly polarized 115th Congress, Republican and Democratic Senate leaders announced a two-year budget deal that would increase federal spending for defense as well as key domestic priorities, including many health programs.
Read More »


Coping With Cancer

“Talking to Doctors about your Bucket List Could Help Advance Care Planning”

VJ Periyakoil (@palliator), lead author of a new study that found 91% of 3,056 U.S. participants surveyed had made a bucket list, discusses how bucket lists can aid talks about life goals, health and advance care planning: https://t.co/vFdktPV4DZ pic.twitter.com/PgySgT4FgE

— Stanford Medicine (@StanfordMed) February 8, 2018

Stanford Medicine News — A Stanford study has found that a majority of people make bucket lists and suggests they can be useful in doctor-patient discussions about care plans.
Read More »


Cancer and Health Care Costs

“Price Transparency for Whom? In Search of Out-of-Pocket Cost Estimates to Facilitate Cost Communication in Cancer Care”

Price Transparency for Whom? In search of out-of-pocket cost estimates to facilitate cost communication in cancer care

Our editorial with Tina Shih and @sfuldnasso #financialtoxicityhttps://t.co/BWLTzbfVaK@DukeCancer @MDAndersonNews @dukemargolis @CancerAdvocacy

— Yousuf Zafar, MD MHS (@yzafar) February 6, 2018

By Ya-Chen Tina Shih, Shelley Fuld Nasso, and S. Yousuf Zafar, PharmacoEconomics — High costs of cancer drugs have repeatedly provoked a public outcry over affordability of cancer care in news media and journal articles. Especially for patients diagnosed with cancer in the United States, the sustained increase in the cost of cancer care is believe to cause tremendous distress for patients and their families to the extent that the term ‘financial toxicity’ has been used to describe patients’ cost-related experiences, and coping strategies are being discussed.
Read More »

“Association of Patient Out-of-Pocket Costs with Prescription Abandonment and Delay in Fills of Novel Oral Anticancer Agents”

Important study in @JCO_ASCO: The more #cancer patients pay for oral chemo, the more likely they are to stop taking those drugs. Why?:

1) high drug prices
2) more cost-sharing
3) clinicians not talking costs w/ptshttps://t.co/Z8IEONqZpm #financialtoxicity @CostsofCare pic.twitter.com/1K9JDLdL3z

— Yousuf Zafar, MD MHS (@yzafar) February 8, 2018

ASCO’s Journal of Clinical Oncology — The number of novel oral anticancer agents is increasing, but financial barriers may limit access. We examined associations between out-of-pocket (OOP) costs and reduced and/or delayed treatment initiation.
Read More »

“Is Federal Policy Really To Blame For The High Cost of Cancer Care?”

Research on hospital mergers & cancer drug pricing shows how “difference-in-difference” analyses can help sort out "cause-and-effect." The finding serves as a reminder to be careful about leaping from a time trend to a cause-and-effect explanation. https://t.co/18EwG9kVYe pic.twitter.com/bwBJ4hHm96

— Peter Ubel (@peterubel) February 8, 2018

By Peter Ubel, Forbes.com — U.S. healthcare costs have been high for decades, outpacing other developed countries since at least the 1980s. But costs continue to rise, and that is causing many experts to ask why. Some people blame federal policies. As an example, they point to reimbursement policies that create incentives for healthcare providers to consolidate. When hospitals merge with each other, or when hospitals buy out physician practices, healthcare providers gain negotiating leverage over insurers, which enables them to negotiate higher prices.
Read More »

“Drugs Don’t Work If People Can’t Afford Them: The High Price of Tisagenlecleucel”

Drugs don’t work if people can’t afford them. Americans deserve transparency in pricing decisions for durigs invented using taxpayer funding. @P4AD_ @PORTAL_Research https://t.co/m9vgX12tTF

— Health Affairs (@Health_Affairs) February 8, 2018

Via Health Affairs Blog — In a system in which life-saving drugs are developed with direct and indirect taxpayer support and afforded market protection through government-granted exclusivities, patients deserve to know how drug manufacturers are arriving at ever-higher prices for their products. Without such information—and subsequent policy reforms based on it—treatment will become increasingly unaffordable. Sadly, for many Americans, it already has; 21 percent of 1,204 respondents in a December 2016 Henry J. Kaiser Family Foundation survey reported that they or a family member did not fill a prescription in the past year because of cost.
Read More »


More From “What Caught Our Eye” »

Follow us on Twitter: @CancerAdvocacy


Tags: affordable care act, cancer care, care planning, drug pricing, financial issues, financial toxicity, Medicaid, What Caught Our Eye
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
https://canceradvocacy.org/wp-content/uploads/2017/01/NCCS-Starburst-250px.png 250 250 actualize https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2018-02-09 17:31:302018-02-09 17:31:30What Caught Our Eye: Medicaid Coverage Limits; Cancer Care Cost Communication; Stanford Care Planning Study; Drug Pricing; and More

Latest News

NCCS Letter to HHS

NCCS Urges CMS to Preserve Access to DIEP Flap Breast Reconstruction

June 1, 2023
Today, the Centers for Medicare and Medicaid Services (CMS) hosted a public meeting, in which they sought input on its decision to…
Read more
https://canceradvocacy.org/wp-content/uploads/HHS-Humphrey-bldg-1200-1030x515-1.jpg 515 1030 Kara Kenan https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png Kara Kenan2023-06-01 16:53:292023-06-01 16:53:29NCCS Urges CMS to Preserve Access to DIEP Flap Breast Reconstruction

Webinar – Survivorship at Atrium Health Wake Forest Baptist Comprehensive Cancer Center: Creating a Practical Workflow

May 12, 2023
The National Coalition for Cancer Survivorship (NCCS) hosted a Survivorship Champions webinar about survivorship care implementation,…
Read more
https://canceradvocacy.org/wp-content/uploads/Atrium-Health-Wake-Forest-Baptist-update-POST.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2023-05-12 12:42:192023-05-12 21:48:11Webinar – Survivorship at Atrium Health Wake Forest Baptist Comprehensive Cancer Center: Creating a Practical Workflow

Sandra Finestone, PsyD: Be Bold and Don’t Hesitate – A 30-year Survivor’s Advice on Advocacy

May 8, 2023
Advocate Spotlight: Sandra Finestone, PsyD A cancer diagnosis can be overwhelming and life-changing, but for Sandra Finestone, it…
Read more
https://canceradvocacy.org/wp-content/uploads/Sandra-Finestone-Advocate-Spotlight-Blog-Banner.png 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2023-05-08 13:42:472023-05-11 10:49:23Sandra Finestone, PsyD: Be Bold and Don’t Hesitate – A 30-year Survivor’s Advice on Advocacy

Take Action

Make An Impact

We are relentless in improving the quality of care and life after a cancer diagnosis. Your support makes all the difference right now.

Make a Gift »

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • This field is for validation purposes and should be left unchanged.

  • About
    • Our Mission
    • Our History
    • The 1986 Club
    • Our Team
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • State of Survivorship Survey
      • 2022 Survey
      • 2021 Survey
      • 2020 Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Advocate Engagement Opportunities
    • Survivorship Champions
    • Subscribe to NCCS Updates
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State-Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Cancer Rehabilitation
    • Integrative Oncology
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Telehealth
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • 2022 Winners
      • Awardees
      • Reception and Sponsorship
      • Committees
      • Nominations
    • Cancer Policy Roundtable (CPR)
      • Fall 2022 CPR
      • Spring 2022 CPR
      • Fall 2021 CPR
      • Spring 2021 CPR
      • Fall 2020 CPR
      • Spring 2020 CPR
    • Cancer Policy and Advocacy Team (CPAT) Virtual Symposium 2022
    • 2022 State of Survivorship Survey Results
    • Webinars
  • Contact Us

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2023 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

ACA Update February 2, 2018 | GOP Unlikely to Try ACA Repeal Again as Trump...ProtectOurCare 1024pxProtectOurCare 1024pxACA Update February 16, 2018 | Idaho Insurer Rolls Out Health Plans That Violate...
Scroll to top
Download the Survey Report

"*" indicates required fields

Fill out the form below, and we’ll send the survey report, detailed presentation, and infographic to your email.
Name*
I am a...*
Select any/all that apply.
Consent*
By downloading the survey materials, you will receive updates and information from NCCS via email, which you may unsubscribe from at any time. Your information will never be sold to any third parties.
This field is for validation purposes and should be left unchanged.

Get Updates From NCCS

Be the first to hear about cancer policy and survivorship issues! Subscribe and receive the biweekly NCCS Health Care Roundup, invites to webinars and events, and more.

  • This field is for validation purposes and should be left unchanged.

Connect With Us

Twitter     Facebook     Instagram     LinkedIn     YouTube

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute